Ventripoint Diagnostics Ltd., a pioneer in advanced cardiac imaging, announced a strategic collaboration with the Ollie Hinkle Heart Foundation (OHHF) to expand access to AI-powered cardiac imaging and clinical decision-support technology for children and adults living with congenital and childhood-onset heart disease. The partnership, announced June 26, 2026, combines Ventripoint's VMS+™ platform with OHHF's Take Heart Collective Impact Model, which unites healthcare providers, innovators, researchers, patients, families, and social partners including Jovie's Joy and Ella's Umbrella.
Under the collaboration, OHHF will initially provide financial support to place two VMS+™ systems within its healthcare partner network, with additional opportunities for education, advocacy, research, technology adoption, and community engagement initiatives. Ventripoint's VMS+™ platform uses artificial intelligence and advanced cardiac modeling to deliver highly accurate measurements of heart structure and function from a standard echocardiogram. By providing sophisticated cardiac insights in a more accessible and efficient manner, VMS+™ enhances clinical decision-making, supports ongoing patient monitoring, and broadens access to advanced cardiac assessment across a range of heart conditions.
“Improving outcomes for people living with heart disease begins with access to accurate, timely, and affordable cardiac imaging,” said Joe Hostetter, Director of the Congenital Heart Disease Program at Ventripoint Diagnostics. “Ollie Hinkle Heart Foundation has become a respected leader in bringing together families, clinicians, healthcare systems, and innovators to solve complex challenges facing children and families impacted by heart disease. Together, we have an opportunity to expand access to advanced imaging solutions that help clinicians make more informed decisions and improve care throughout a patient's journey.”
The partnership is deeply rooted in the lived experiences of families who understand the critical need for better information, safer testing options, and more informed treatment decisions. Katie Nesselbush, Founder of Jovie's Joy and Social Partner of OHHF, shared her perspective: “As a mother of a child living with dilated cardiomyopathy, I know firsthand the impossible decisions families can face when trying to get answers about their child's heart. Technologies like Ventripoint give physicians more information to guide care while reducing barriers and risk for families. Every parent wants confidence that they're making the best possible decisions for their child, and every child deserves access to the most advanced tools available.”
Mark Hinkle, Co-Founder of OHHF, emphasized the personal motivation behind the collaboration: “When our son Ollie passed away at just 13 months old, we learned firsthand how quickly a child's condition can change. We can't change Ollie's story, and we can't bring Ella back. But we can honor them by ensuring more children have access to the technology, information, and treatment options they never had. That's the future we're building through the Take Heart Collective Impact Model.”
The implications of this partnership are significant for the pediatric cardiology community. By integrating AI-driven imaging into clinical workflows, the collaboration aims to reduce barriers to advanced cardiac imaging, such as cost, accessibility, and the need for multiple tests. For healthcare leaders, this model demonstrates how strategic alliances between technology companies and patient advocacy groups can accelerate the adoption of innovative solutions, potentially improving outcomes for children with heart disease worldwide. The partnership also highlights the growing role of artificial intelligence in democratizing advanced diagnostics, making them available in a wider range of clinical settings.
About Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Ltd. (TSXV: VPT, OTCQB: VPTDF) is an industry leader in applying AI to echocardiography. Its VMS products, powered by proprietary Knowledge Based Reconstruction technology, provide accurate volumetric cardiac measurements equivalent to MRI. VMS+ is compatible with all ultrasound systems and has regulatory approvals in the U.S., Europe, and Canada. For more information, visit www.ventripoint.com.
About the Ollie Hinkle Heart Foundation: OHHF transforms pediatric heart care through its Take Heart Collective Impact Model, aligning healthcare systems, innovators, researchers, nonprofits, patients, families, and community partners to accelerate innovation and improve outcomes. For more information, visit www.ohhf.org.
